Pascual Santos, Julio; Berger, Stefan; Chadban, Steven J.; Citterio, Franco; Kamar, Nassim; Hesselink, Dennis A.; Legendre, Christophe; Eisenberger, Ute; Oppenheimer, Federico; Russ,Graeme R.; Sommerer, Claudia; Rigotti, Paolo; Srinivas, Titte R.; Watarai, Yoshihiko; Henry, Mitchell L.; Vincenti, Flavio; Tedesco-Silva, Helio
(Elsevier, 2019)
The mammalian target of rapamycin (mTOR) inhibitor, everolimus, in combination with reduced-exposure calcineurin inhibitor (CNI), has been demonstrated in clinical trials to have comparable efficacy in low-to-moderate ...